hyperaldosteronism
HYPERALDOSTERONISM
Hyperaldosteronism is a group of disorders in which aldosterone production is inappropriately high, relatively autonomous & non-suppressible by sodium loading.
Signs & symptoms are nonspecific.
Symptoms are caused by hypertension (eg headache), hypokalemia (eg polyuria, nocturia, muscle cramps & weakness, tetany, paralysis, etc) & metabolic alkalosis.

Definition

  • Hyperaldosteronism is a group of disorders in which aldosterone production is inappropriately high, relatively autonomous and non-suppressible by sodium loading

Etiology

  • Hyperplasia eg idiopathic (bilateral) hyperplasia, primary (unilateral) adrenal hyperplasia
  • Familial Hyperaldosteronism II
    • Non-glucocorticoid remediable; maybe associated with familial occurrence of aldosterone-producing adenoma, idiopathic hyperaldosteronism, or both
Glucocorticoid-Remediable Aldosteronism (Familial Hyperaldosteronism I)
  • Monogenetic disorder related to hypertension
  • Adrenocortical hyperplasia is present which may be nodular
    • Histological features suggest over activity of the zona fasciculata
    • Progression to tumor has not been reported
  • Patients are usually asymptomatic young hypertensives
  • Diagnosis may be made with suppression of plasma aldosterone with Dexamethasone or southern blotting of genetic defect
  • Treat with low-dose Dexamethasone
Apparent Mineralocorticoid Excess
  • Rare congenital condition
  • Spironolactone may be used to control electrolyte imbalance
  • Blood pressure (BP) control usually needs other antihypertensive agents
    • Eg Angiotensin-converting enzyme (ACE) inhibitors, thiazide diuretics
  • Low-dose Dexamethasone may be useful

Liddle’s Syndrome

  • Rare congenital condition
  • Treat with Spironolactone but may also require Amiloride or Triamterene

Signs and Symptoms

  • Signs and symptoms are nonspecific
    • Symptoms caused by hypertension (eg headache), hypokalemia (eg polyuria, nocturia, muscle cramps and weakness, tetany, paralysis, etc), and metabolic alkalosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jun 2015
Long-term oral testosterone undecanoate significantly improved IPSS quality of life scores in a 1-year, randomised, multicentre, double-blind trial among aging hypogonadal men.
Rachel Soon, 01 Jun 2016

The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Rachel Soon, 01 Jun 2016

Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Prof. Cyrus Rustam Kumana, 07 Jul 2016

This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.